Wei Wang

Dr. Wei Wang


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2023 in Pharmaceuticals
Verified
Journal Article
Open access
PDF file
YTYijing Tao
Yijing Tao
WWWei Wang
Wei Wang
YJYihua Jin
Yihua Jin
MWMin Wang
Min Wang
JXJiawen Xu
Jiawen Xu
FGFang-qi Gong
Fang-qi Gong
The EphrinB2/EphB4 signaling pathway involves the regulation of vascular morphogenesis and angiogenesis. However, little is known about EphrinB2/EphB4 in the pathogenesis of Kawasaki disease (KD) and coronary artery aneurysm formation. Hence, this study aimed to explore the role of EphrinB2/EphB4 and the potential therapeutic effect of EphrinB2-Fc in the coronary arterial endothelial injury of KD. The levels of EphB4 were compared between KD patients and healthy children. Human coronary artery endothelial cells (HCAECs) were stimulated with sera from acute KD patients to establish the KD cell model. The overexpression of EphB4 or treatment with EphrinB2-Fc was found to intervene in the cell model. The cell migration, angiogenesis, and proliferation ability were assessed, and the expression of inflammation-related factors was measured. Our study showed that EphB4 showed low expression in both KD patients and the cell model of KD. The EphB4 protein levels in the CECs of CAA+ KD patients were much lower than those in healthy children. EphrinB2-Fc treatment of KD sera-activated HCAECs suppressed cell proliferation, reduced the expression of inflammation-related factors (such as IL-6 and P-selectin), and elevated cell angiogenesis ability. The results reveal that EphrinB2-Fc has a protective function in endothelial cells and has promising clinical applications for protecting vascular endothelium in patients with KD.

15 September 2026 in Scientific Data
Verified
Journal Article
Open access
PDF file
HXHaiyan Xu
Haiyan Xu
YCYu Cao
Yu Cao
XLXiaohan Li
Xiaohan Li
JYJian Yang
Jian Yang
YFYuqing Feng
Yuqing Feng
WWWei Wang
Wei Wang
Electrocardiogram (ECG) is a widely used non-invasive method for diagnosing cardiovascular diseases. ECG signal characteristics vary markedly across age groups, with pediatric recordings differing substantially from those of adults. Establishing a reliable baseline for defining a “normal” pediatric ECG across developmental stages is essential prior to designing algorithms for abnormality detection. Existing ECG databases are predominantly composed of adult data and lack comprehensive age stratification, while a few pediatric ECG databases are only from hospitalized children, resulting in a scarcity of large-scale, publicly available pediatric datasets that accurately reflect typical cardiac physiology of children. To address this gap, we present a large-scale, standardized pediatric normal ECG dataset comprising recordings from children aged 0-6 years. The dataset was compiled from a larger collection acquired at the Children’s Hospital, Zhejiang University School of Medicine, between 2019 and 2023. It includes 58,672 standardized 12-lead ECG recordings, each 10 seconds in duration and sampled at 500 Hz, all annotated as “NORM” by experienced pediatric cardiologists. This resource aimed to serve as a high-quality reference baseline for pediatric ECG research and algorithm development.

3 April 2026 in JACC: Case Reports
Verified
Journal Article
Open access
YWYujia Wang
Yujia Wang
HWHuafeng Wang
Huafeng Wang
HXHaiyan Xu
Haiyan Xu
FGFangqi Gong
Fangqi Gong
YZYing Zhou
Ying Zhou
WWWei Wang
Wei Wang
Pediatric LMNA-related dilated cardiomyopathy (DCM) carries extreme risks of malignant arrhythmias and sudden cardiac death. While cardiac resynchronization therapy with defibrillator (CRT-D) is life-saving, small body size and coronary anatomy make lead stability technically challenging. An 11-year-old boy with LMNA-related DCM (c.1622G>A, p.R541H) experienced ventricular fibrillation arrest requiring extracorporeal membrane oxygenation support. A CRT-D was implanted using an active-fixation quadripolar left ventricular (LV) lead in the coronary vein. Subsequent refractory ventricular tachycardia was managed with epicardial radiofrequency ablation. Postoperatively, LV ejection fraction improved from 16% to 35.9%, and QRS duration narrowed from 150 to 120 ms. No arrhythmia recurrence was observed at the 3-month follow-up. Adapting adult active-fixation technology for the pediatric anatomy ensures lead stability. An integrated "dual-track" strategy-combining resynchronization with epicardial ablation-effectively manages the malignant electromechanical phenotype in high-risk LMNA carriers. Active-fixation LV leads, integrated with epicardial ablation, provide a stable and effective "dual-track" strategy for managing malignant arrhythmias in pediatric LMNA-mutation carriers.

Verified
Journal Article
Open access
PDF file
XSXiaodong Sun
Xiaodong Sun
HWHuafeng Wang
Huafeng Wang
YWYujia Wang
Yujia Wang
FGFang-qi Gong
Fang-qi Gong
LYLiyang Ying
Liyang Ying
WWWei Wang
Wei Wang
Background/Objectives: Children with congenital long QT syndrome (cLQTS) are at extremely high risk of torsades de pointes (TdP) and sudden cardiac death (SCD). Although the implantable cardioverter-defibrillator (ICD) is a cornerstone in SCD prevention, traditional transvenous ICDs are associated with venous access occupation, lead wear or fracture due to somatic growth, and difficulties with long-term lead revision or extraction. The extravascular ICD, which places the lead in the substernal extravascular space, has the potential to circumvent these lead-related complications. We report the experience of successful extravascular ICD implantation in a young child with drug-refractory cLQTS type 2 (cLQTS2). Methods: The clinical data of a 9-year-old boy with cLQTS2 were retrospectively analyzed. The patient carried a heterozygous KCNH2 variant (c.1810G>A, p.Gly604Ser) and had been on long-term oral propranolol and mexiletine. He presented with a cardiac arrest out of hospital during nocturnal sleep, was transferred to our hospital after successful cardiopulmonary resuscitation, and had TdP captured on ambulatory monitoring. Following multidisciplinary discussion, preoperative chest computed tomography (CT) assessment of the substernal anatomy, and informed consent, extravascular ICD implantation was performed on hospital day 11. The procedure involved the creation of a substernal tunnel via a subxiphoid incision, placement of the defibrillation lead in the anterior mediastinum with lead slack reserved for growth, and positioning of the pulse generator in a left axillary subcutaneous pocket. Intraoperative defibrillation testing succeeded with a single 30 J shock. Results: The postoperative recovery was uneventful without procedure-related complications. At the 2-month follow-up, device parameters were satisfactory and no inappropriate shocks had occurred. The corrected QT interval (QTc) decreased from 563 ms on admission to 522 ms. Ambulatory monitoring detected asymptomatic episodes of non-sustained ventricular tachycardia, but no ventricular fibrillation or syncope was observed. Venous access was fully preserved. Conclusions: In children with drug-refractory cLQTS2, the extravascular ICD provides defibrillation and antitachycardia pacing (ATP) while avoiding transvenous lead complications and preserving venous access. This case shows that with precise preoperative planning and lead redundancy, the device appears feasible and can be implanted without short-term complications in young children. Larger studies with longer follow-up are needed to evaluate long-term device performance.

10 November 2026 in Children
Verified
Journal Article
Open access
PDF file
FXFanqing Xu
Fanqing Xu
WWWei Wang
Wei Wang
HZHuimin Zhang
Huimin Zhang
YZYan Zhang
Yan Zhang
HXHaiyan Xu
Haiyan Xu
Background: Multiple accessory pathways are uncommon in pediatric Wolff–Parkinson–White syndrome and may cause dynamic changes in ventricular pre-excitation, complicating electrocardiographic localization. Case presentation: A 7-year-old girl with recurrent palpitations and syncope exhibited variable QRS morphology and delta-wave patterns. Electrophysiological findings were consistent with orthodromic atrioventricular reentrant tachycardia. Sequential CARTO mapping identified three spatially separated right-sided accessory pathway sites. Ablation of AP1 (7 o’clock, tricuspid annulus) and AP2 (11 o’clock, tricuspid annulus) produced successive QRS morphological changes without eliminating pre-excitation. AP3 was localized just superior to the coronary sinus ostium at approximately the 4 o’clock position, where ablation eliminated pre-excitation. No tachycardia was inducible immediately afterward. However, pre-excitation reappeared on ECG at 1-month follow-up and persisted at 3 months, with two patient-reported tachycardia episodes but no recurrent syncope. Conclusions: Dynamic pre-excitation patterns may suggest multiple accessory pathways. Sequential mapping and electrocardiographic reassessment can help identify residual pathway conduction, although acute procedural success does not ensure sustained elimination of pre-excitation.